The International immunosuppression & Transplant Skin Cancer Collaborative (ITSCC) is an organization of dermatologic surgeons, clinicians and researchers from multiple disciplines dedicated to advancing the care and understanding of skin cancer in organ transplant recipients.
These patients are up to 65 times more likely to develop skin cancer than people without transplants. Skin cancer is the most common cancer affecting solid organ transplant recipients, affecting up to 70 percent of patients within 20 years, and is the result of intense immunosuppressive regimens.
ITSCC was founded in 2001 by a group of dermatologic surgeons from several institutions who saw the need to better manage skin cancers in patients who received solid organ transplants. These patients are up to 65 times more likely to develop skin cancer than people without transplants.
A multi-center collaborative research project conducted at the Mayo Clinic focused on metastatic skin cancer in transplant patients revealed that many physicians were facing challenges treating skin cancers in organ transplant recipients.
A collaborative group, under the name North American Transplant Skin Cancer Collaborative, formed around a shared dedication to finding optimal care for the skin and skin cancer of these patients. As membership diversified to include physicians and researchers from Central and South America, Australia, and other regions, the name was changed to ITSCC.
- To integrate and support basic scientific and clinical research to address the special needs of immunosuppressed patients and organ transplant recipients with skin cancer in order to improve quality of care.
- To educate patients, scientists, primary care doctors and specialist physicians on the unique needs and clinical care issues in immunosuppressed and transplant patients.
Your tax-deductible donation supports the education and research of physicians and scientists committed to improving the quality of life of organ transplant recipients. If you are unable to donate online or require other information to make a gift through a trust or other source, email firstname.lastname@example.org for additional assistance. ITSCC's federal tax ID is 43-1964114.
ITSCC is a nonprofit 501(c)(3) organization, and has received support through unrestricted educational grants from pharmaceutical companies and donations of time and funds from physicians, researchers, transplant patients and their families.